Physician profile
Karan Gupta
NPI 1104219161
$25,105.27
in general payments reported to CMS, 2019-2025
35 companies · $5,767 in 2025
The $5,767 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $140 · 2021: $1,904 · 2022: $1,311 · 2023: $8,678 · 2024: $6,569 · 2025: $5,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $5,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,538.61 |
| Travel and Lodging | $5,475.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $8,969.06 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $4,456.00 | 2022-2025 | Mitraclip, Triclip, Esprit |
| Shockwave Medical, INC | $2,900.71 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $2,244.08 | 2021-2025 | Comet, Avvigo Guidance System, Synergy |
| Medtronic, INC. | $1,545.18 | 2021-2025 | Micra, Onyx Frontier, Corevalve Evolut R |
| Abiomed | $1,059.93 | 2021-2025 | Impella |
| Cvrx, INC. | $584.19 | 2024-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $572.79 | 2019-2020 | |
| Pfizer INC. | $316.43 | 2019-2025 | |
| Biotronik INC. | $268.18 | 2024 | Biomonitor, Recross |
| Janssen Pharmaceuticals, INC | $264.44 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $240.48 | 2019-2024 | Farxiga, Andexxa |
| Medical Device Business Services, INC. | $168.10 | 2022 | |
| Impulse Dynamics (USA) INC. | $157.81 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $145.22 | 2022-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $136.02 | 2019-2024 | |
| Inari Medical, INC. | $130.68 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $122.78 | 2023-2025 | Uptravi, Opsumit |
| Philips North America LLC | $93.98 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $92.16 | 2023-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $77.17 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.21 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.18 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $50.13 | 2024-2025 | |
| Acist Medical Systems, INC. | $35.44 | 2025 | |
| Biosense Webster, INC. | $34.31 | 2021 | |
| Scpharmaceuticals INC. | $30.06 | 2024-2025 | |
| Daiichi Sankyo INC. | $29.24 | 2023 | Injectafer |
| Angiodynamics, INC. | $26.88 | 2025 | Auryon Laser System 100-120 Vac |
| Innovation Technologies INC | $24.63 | 2024 | Irrisept |
| Kiniksa Pharmaceuticals, LTD. | $22.82 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $18.86 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $18.29 | 2025 | Inspire |
| Novo Nordisk INC | $16.49 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.